Hemanext
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Hayden Avenue Building B 99 Ste 620, Lex...Phone Number
(781) 301-7474Website
www.hemanext.comRevenue
$15.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Hemanext
Hermannext is a medical technology company based in Massachusetts. The company has manufactured a medical device to process and store eligible red blood cells.Explore more
Hemanext Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hemanext your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Hemanext had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Hemanext launches new products
Congratulate Masked Content for being promoted to Masked Content at Hemanext
Earning: See what the market has to say on Hemanext recently announced quarterly report
Funding: Get notified immidiatlly once Hemanext has new funding data
Hemanext, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Hemanext is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Hemanext has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Hemanext
Compare insights from companies similar to Hemanext, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Hemanext is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hemanext is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hemanext.
Hemanext financials insights
Gather financial insights about Hemanext, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Private Equity
$12.3M
2017
Private Equity
$2.7M
2018
Debt
$2M
2020
Debt
$350K
2021
Series A
$15M
2022
Series B
$18M
2025
Multiple Rounds
$80.6M
Hemanext Tech Stack
A closer look at the technologies used by Hemanext
Most Recent Scoops
Lateral Move
Executive Move
Executive Moves, Lateral Move
Promotion
Executive Moves
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Funding
Funding
Hemanext News & Media
Hemanext ONE® Receives 510(k) Clearance for Expanded Indications for Use in the United States
Hemanext Inc. today announced that the Hemanext ONE® System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded indications for use in the United States. The expanded Indications for Use enable processing of whole blood and apheresis-derived AS-3 leukocyte-reduced red blood cells. [PR.com]Shane Ray Appointed as President and Chief Executive Officer of Hemanext
Hemanext Inc., a leading innovator in blood processing, storage and transfusion technology, is pleased to announce that the Board has appointed Shane Ray to take on the role of President and Chief Executive Officer of Hemanext from Andy Dunham. Shane will also retain his role as the Chief Commercial Officer to lead the global commercial strategy and sales team while Andy will remain on the Executive Leadership Team as [PR.com]Hemanext Inc. Awarded $2.9M NIH Grant to Advance Clinical Initiatives in the United States
Hemanext Inc has been awarded a three-year Small Business Innovation Research Grant (SBIR) Phase II for a project titled, “Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia,” to support and strengthen the clinical efforts of hypoxically stored red blood cells (HRBC) in the United States. [PR.com]New Chief Commercial Officer Joins Hemanext Team to Drive Execution
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, is pleased to welcome Mr. Shane Ray to the team as Chief Commercial Officer (CCO). In this role, Shane will lead the global commercial strategy and execution for Hemanext ONE®. [PR.com]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hemanext
Sign Up For FreeTo access detailed company insights
Hermannext is a medical technology company based in Massachusetts. The company has manufactured a medical device to process and store eligible red blood cells.... Read More
